Echo Core Lab News Today : Breaking News, Live Updates & Top Stories | Vimarsana

(0)
- Published in the
New England Journal of Medicine (NEJM), the REDUCE Study continues to show the largest reduction in recurrent ischemic stroke in all PFO shunt sizes over medical therapy alone.
,¹
CARDIOFORM Septal Occluder can be trusted for patient safety and effective defect closure.
FLAGSTAFF, Ariz., March 11, 2021 /PRNewswire/ W. L. Gore & Associates (Gore), today announced that Gore REDUCE Study long-term follow-up results were published in the March 2021 issue of
The New England Journal of Medicine (NEJM), highlighting the benefits of patent foramen ovale (PFO) closure. The extended follow-up data further supports the use of GORE CARDIOFORM Septal Occluder in long-term recurrent stroke prevention. ....

United States , Kostenloser Wertpapierhandel , Johnf Rhodes , John Laschinger , Wl Gore Associates , Wl Gore Associates Inc , Drug Administration , Us Cardiology National Principal Investigator , Prnewswire Wl Gore Associates , University Of South Carolina , European Union , Echo Core Lab , New England Journal , Gore Device , Medical University , South Carolina , National Principal Investigator , Cardiac Chief Medical , Echo Core , England Journal , ஒன்றுபட்டது மாநிலங்களில் , வில் கார் கூட்டாளிகள் , வில் கார் கூட்டாளிகள் இன்க் , எங்களுக்கு இருதயவியல் தேசிய ப்ரிந்ஸிபல் புலனாய்வாளர் , பல்கலைக்கழகம் ஆஃப் தெற்கு கரோலினா , ஐரோப்பிய தொழிற்சங்கம் ,